Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cadherins | 7 | 2019 | 93 | 2.710 |
Why?
|
| Adherens Junctions | 4 | 2018 | 13 | 1.910 |
Why?
|
| Cell Adhesion | 4 | 2017 | 324 | 1.590 |
Why?
|
| Catenins | 4 | 2016 | 8 | 1.270 |
Why?
|
| RNA Interference | 7 | 2018 | 266 | 1.060 |
Why?
|
| MicroRNAs | 4 | 2017 | 447 | 0.970 |
Why?
|
| Breast Neoplasms | 5 | 2015 | 1533 | 0.830 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2006 | 42 | 0.820 |
Why?
|
| Neoplasms | 5 | 2017 | 1660 | 0.790 |
Why?
|
| Carrier Proteins | 6 | 2018 | 597 | 0.760 |
Why?
|
| Epithelial Cells | 3 | 2017 | 431 | 0.750 |
Why?
|
| Colonic Diseases | 1 | 2019 | 36 | 0.690 |
Why?
|
| Mytilus | 3 | 2008 | 3 | 0.670 |
Why?
|
| Colon | 1 | 2019 | 168 | 0.650 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2017 | 3 | 0.630 |
Why?
|
| Homeostasis | 1 | 2019 | 291 | 0.620 |
Why?
|
| Focal Adhesions | 2 | 2016 | 25 | 0.580 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 135 | 0.550 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2016 | 756 | 0.530 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 108 | 0.520 |
Why?
|
| RNA, Messenger | 2 | 2017 | 1663 | 0.520 |
Why?
|
| Signal Transduction | 7 | 2019 | 2688 | 0.510 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 199 | 0.510 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 110 | 0.490 |
Why?
|
| Phosphoproteins | 1 | 2015 | 202 | 0.480 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 206 | 0.480 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 235 | 0.470 |
Why?
|
| Guanine Nucleotide Exchange Factors | 4 | 2013 | 19 | 0.460 |
Why?
|
| Receptor, ErbB-2 | 2 | 2010 | 128 | 0.410 |
Why?
|
| Cell Proliferation | 6 | 2018 | 1173 | 0.390 |
Why?
|
| Animals | 18 | 2019 | 20877 | 0.390 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2010 | 1 | 0.370 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2010 | 3 | 0.370 |
Why?
|
| Genes, erbB-2 | 1 | 2010 | 15 | 0.370 |
Why?
|
| Palmitates | 1 | 2009 | 20 | 0.350 |
Why?
|
| Evolution, Molecular | 2 | 2006 | 79 | 0.330 |
Why?
|
| PPAR gamma | 1 | 2009 | 95 | 0.330 |
Why?
|
| Phylogeny | 2 | 2006 | 196 | 0.320 |
Why?
|
| DNA, Satellite | 1 | 2006 | 4 | 0.300 |
Why?
|
| Introns | 1 | 2006 | 68 | 0.290 |
Why?
|
| DNA Transposable Elements | 1 | 2006 | 20 | 0.290 |
Why?
|
| Apoptosis | 3 | 2013 | 1640 | 0.290 |
Why?
|
| Mollusca | 1 | 2006 | 14 | 0.280 |
Why?
|
| Genomics | 1 | 2007 | 167 | 0.270 |
Why?
|
| src-Family Kinases | 2 | 2016 | 91 | 0.270 |
Why?
|
| Humans | 23 | 2019 | 68525 | 0.260 |
Why?
|
| Bivalvia | 1 | 2005 | 10 | 0.260 |
Why?
|
| Dogs | 5 | 2017 | 490 | 0.250 |
Why?
|
| Madin Darby Canine Kidney Cells | 4 | 2017 | 22 | 0.250 |
Why?
|
| Molecular Sequence Data | 6 | 2014 | 1446 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 3 | 2015 | 852 | 0.210 |
Why?
|
| Models, Biological | 4 | 2018 | 981 | 0.200 |
Why?
|
| Base Sequence | 5 | 2014 | 1015 | 0.190 |
Why?
|
| Caco-2 Cells | 2 | 2017 | 37 | 0.190 |
Why?
|
| Microtubules | 3 | 2016 | 104 | 0.180 |
Why?
|
| Phosphorylation | 4 | 2015 | 1199 | 0.170 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 1849 | 0.160 |
Why?
|
| Oncogene Protein p65(gag-jun) | 1 | 2017 | 1 | 0.160 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 20 | 0.160 |
Why?
|
| Protein Binding | 3 | 2015 | 1027 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 121 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 90 | 0.150 |
Why?
|
| RNA | 1 | 2018 | 171 | 0.150 |
Why?
|
| Cytoplasm | 2 | 2008 | 155 | 0.150 |
Why?
|
| RNA-Binding Proteins | 2 | 2016 | 215 | 0.150 |
Why?
|
| ErbB Receptors | 1 | 2018 | 239 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2016 | 51 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 267 | 0.140 |
Why?
|
| Cofilin 1 | 1 | 2016 | 6 | 0.140 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 114 | 0.140 |
Why?
|
| Threonine | 1 | 2015 | 47 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 214 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 53 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 196 | 0.130 |
Why?
|
| Serine | 1 | 2015 | 99 | 0.130 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 132 | 0.130 |
Why?
|
| Tyrosine | 1 | 2015 | 196 | 0.130 |
Why?
|
| Actins | 1 | 2016 | 249 | 0.120 |
Why?
|
| Aptamers, Nucleotide | 1 | 2014 | 15 | 0.120 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 32 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1034 | 0.120 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2013 | 6 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 65 | 0.120 |
Why?
|
| Transfection | 2 | 2018 | 782 | 0.120 |
Why?
|
| 14-3-3 Proteins | 1 | 2013 | 12 | 0.110 |
Why?
|
| Angiopoietin-1 | 1 | 2012 | 12 | 0.110 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 32 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2013 | 84 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2015 | 954 | 0.110 |
Why?
|
| Protein Transport | 4 | 2015 | 280 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 195 | 0.110 |
Why?
|
| Cell Communication | 1 | 2013 | 116 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 434 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 219 | 0.100 |
Why?
|
| Cell Movement | 1 | 2013 | 630 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 710 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2009 | 231 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 40 | 0.090 |
Why?
|
| Inflammation | 1 | 2016 | 1030 | 0.090 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2010 | 222 | 0.090 |
Why?
|
| Kinetochores | 1 | 2008 | 1 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 134 | 0.080 |
Why?
|
| Spindle Apparatus | 1 | 2008 | 13 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 186 | 0.080 |
Why?
|
| Protein Stability | 3 | 2013 | 89 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 282 | 0.080 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2008 | 46 | 0.080 |
Why?
|
| Mitosis | 1 | 2008 | 76 | 0.080 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2007 | 13 | 0.080 |
Why?
|
| eIF-2 Kinase | 1 | 2008 | 49 | 0.080 |
Why?
|
| HeLa Cells | 3 | 2014 | 237 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2007 | 97 | 0.070 |
Why?
|
| Genetic Techniques | 1 | 2007 | 32 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 562 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 1082 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 614 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 499 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2006 | 67 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2007 | 312 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2006 | 208 | 0.070 |
Why?
|
| Female | 5 | 2018 | 38015 | 0.070 |
Why?
|
| Open Reading Frames | 1 | 2005 | 25 | 0.070 |
Why?
|
| Mice | 6 | 2016 | 8472 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2009 | 753 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 188 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 357 | 0.060 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2013 | 45 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 624 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 196 | 0.050 |
Why?
|
| DNA | 1 | 2005 | 597 | 0.050 |
Why?
|
| Binding Sites | 2 | 2014 | 631 | 0.050 |
Why?
|
| Chick Embryo | 2 | 2009 | 379 | 0.040 |
Why?
|
| Mice, Nude | 2 | 2009 | 294 | 0.040 |
Why?
|
| Phenotype | 2 | 2013 | 946 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 532 | 0.040 |
Why?
|
| Epithelium | 1 | 2016 | 172 | 0.040 |
Why?
|
| Permeability | 1 | 2016 | 131 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2016 | 59 | 0.040 |
Why?
|
| Ribonuclease III | 1 | 2015 | 16 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 43 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 523 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 230 | 0.030 |
Why?
|
| SELEX Aptamer Technique | 1 | 2014 | 1 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2014 | 165 | 0.030 |
Why?
|
| Luciferases | 1 | 2014 | 105 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 80 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2014 | 92 | 0.030 |
Why?
|
| Cell Shape | 1 | 2013 | 37 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2014 | 191 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2013 | 49 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2012 | 69 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 317 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2016 | 283 | 0.030 |
Why?
|
| Breast | 1 | 2013 | 137 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2013 | 326 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2013 | 308 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2013 | 246 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 322 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2673 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 284 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 277 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2012 | 586 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2009 | 71 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 1752 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 58 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2008 | 12 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 94 | 0.020 |
Why?
|
| Mad2 Proteins | 1 | 2008 | 3 | 0.020 |
Why?
|
| Centromere Protein A | 1 | 2008 | 2 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 254 | 0.020 |
Why?
|
| Anaphase | 1 | 2008 | 3 | 0.020 |
Why?
|
| Metaphase | 1 | 2008 | 12 | 0.020 |
Why?
|
| Nocodazole | 1 | 2008 | 11 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 118 | 0.020 |
Why?
|
| Thiones | 1 | 2008 | 16 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 67 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 27 | 0.020 |
Why?
|
| Genome, Human | 1 | 2008 | 62 | 0.020 |
Why?
|
| Genome | 1 | 2008 | 54 | 0.020 |
Why?
|
| Imidazoles | 1 | 2009 | 175 | 0.020 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2008 | 17 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 230 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2008 | 57 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 351 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2012 | 1692 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2012 | 617 | 0.020 |
Why?
|
| Chromatin | 1 | 2008 | 76 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 114 | 0.020 |
Why?
|
| Autoantigens | 1 | 2008 | 91 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2008 | 140 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 320 | 0.020 |
Why?
|
| G1 Phase | 1 | 2007 | 42 | 0.020 |
Why?
|
| S Phase | 1 | 2007 | 38 | 0.020 |
Why?
|
| Nifedipine | 1 | 2007 | 40 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 65 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2007 | 61 | 0.020 |
Why?
|
| Computational Biology | 1 | 2009 | 190 | 0.020 |
Why?
|
| Indoles | 1 | 2008 | 146 | 0.020 |
Why?
|
| DNA Replication | 1 | 2008 | 167 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2008 | 141 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2007 | 73 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2008 | 182 | 0.020 |
Why?
|
| Pyridines | 1 | 2009 | 261 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2008 | 178 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 2007 | 137 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 498 | 0.020 |
Why?
|
| Kinetics | 1 | 2008 | 1047 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 230 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 567 | 0.020 |
Why?
|
| Peptides | 1 | 2008 | 455 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 659 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 901 | 0.020 |
Why?
|
| Calcium | 1 | 2007 | 929 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 902 | 0.010 |
Why?
|